»ÃѺ»Ãا : 7/03/2018
ʶԵԼÙéà¢éÒªÁ:6697118 ¡ÒÃà»Ô´Ë¹éÒàÇçº:9565104 Online User Last 1 hour (0 users)
HIV+ People From Across India and Asia Say ? “DON’T TRADE AWAY OUR LIVES” in the EU-India Free Trade Agreement
02 ÁÕ¹Ò¤Á 2554
Date: 2 March 2011
Source: www.keionline.org
People living with HIV from across Asia who depend on affordable generic
AIDS medicines to stay alive will urge the Indian government to stand
strong against European Union demands on the sensitive intellectual
property (IP) chapter in ongoing free trade agreement (FTA) negotiations.
The EU is pushing for harmful IP provisions to be included in the trade
agreement that will hinder access to quality, affordable generic medicines
produced in India, the ?pharmacy of the developing world.? Affordable
medicines produced in India have played a major role in scaling up AIDS
treatment to more than five million people across Asia, Africa and Latin America.
Roughly 2,000 people living with HIV coming from different parts of India
and Asia are expected to rally alongside the United
Nations Special Rapporteur for the Right to Health in New Delhi to highlight the grave danger this FTA
brings to countless human lives in developing countries by preventing the
production, registration and distribution of quality affordable generic
medicines.
World Trade Organization rules already obligated
India to start granting medicines patents in 2005. This is
preventing production and access to affordable versions of Hepatitis C
drugs and the new generation of cancer and HIV/AIDS drugs, some of which
have already been patented in India.
At a press conference following the rally, patient groups will share their
concerns about the impact of trade agreements on their lives, and will
provide technical background on the intellectual property and investment
provisions in the proposed FTA.